帕瑟诺利德在卵巢癌中逆转了对西斯普拉丁的耐药性:一个观察性网络药理学和分子对接研究
1Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei, P.R. China.
Medicine
|June 30, 2025
概括
帕瑟诺利德可以通过向特定的基因来逆转卵巢癌 (OV) 中的西斯普拉丁耐药性. 这项研究确定了关键的分子机制,支持其在OV治疗中的潜在用途.
科学领域:
- 妇科瘤学 妇科瘤学
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 卵巢癌 (OV) 是全球癌症死亡的主要原因.
- 西斯普拉丁耐药性是OV治疗的一个主要挑战.
- 帕瑟诺利德显示出在OV中克服西斯普拉丁耐药性的潜力.
研究的目的:
- 为了确定帕瑟诺利德的分子标和机制,以逆转OV中西斯普拉丁耐药性.
- 整合网络药理学和分子对接以进行全面分析.
主要方法:
- 从抗和对照OV样本中分析基因表达数据集.
- 鉴定差异表达基因 (DEGs) 和丰富分析.
- 权重基因共同表达网络分析 (WGCNA) 和蛋白质-蛋白质相互作用网络构建.
- 分子对接以预测帕氏化物-蛋白质相互作用.
主要成果:
- 发现了3582个DEG,在与免疫相关的途径中得到丰富.
- 266个重叠的免疫相关基因在抗性OV中发现.
- 像阿波利波蛋白E这样的枢纽基因显示出诊断价值.
- 确定了包括β-2-微型血球蛋白和激活蛋白-1在内的帕氏化物标.
结论:
- 确定了与OV中西斯普拉丁耐药性相关的候选基因.
- 在克服耐药性的过程中,帕瑟诺利德作用的分子机制得到了阐明.
- 这些发现支持帕瑟诺利德作为治疗OV的辅助疗法的潜力.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
330
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
330


